PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Brighton Collaboration, a program of the Task Force for Global Health, Decatur, Georgia USA. Electronic address: stevblack@gmail.com.\', \'The Brighton Collaboration, a program of the Task Force for Global Health, Decatur, Georgia USA.\', \'University of Utrecht, Netherlands.\', \'The Mayo Clinic, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(21)00284-X10.1016/j.vaccine.2021.03.016
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 33846042
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
?:title
  • The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all